A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Autoria(s): Burnett, Alan K; Milligan, Donald; Prentice, Archie G; Goldstone, Anthony H; McMullin, Mary F; Hills, Robert K; Wheatley, Keith
Data(s)

15/03/2007
Identificador

http://pure.qub.ac.uk/portal/en/publications/a-comparison-of-lowdose-cytarabine-and-hydroxyurea-with-or-without-alltrans-retinoic-acid-for-acute-myeloid-leukemia-and-highrisk-myelodysplastic-syndrome-in-patients-not-considered-fit-for-intensive-treatment(ce3caa6d-a0ad-4ddf-866f-a6955d491865).html

http://dx.doi.org/10.1002/cncr.22496

http://www.scopus.com/inward/record.url?scp=33947205565&partnerID=8YFLogxK
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Burnett , A K , Milligan , D , Prentice , A G , Goldstone , A H , McMullin , M F , Hills , R K & Wheatley , K 2007 , ' A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. ' Cancer , vol 109 , no. 6 , pp. 1114-1124 . DOI: 10.1002/cncr.22496
Palavras-Chave #Acute Disease #Aged #Antineoplastic Combined Chemotherapy Protocols #Cytarabine #Female #Humans #Hydroxyurea #Leukemia, Myeloid #Male #Middle Aged #Myelodysplastic Syndromes #Risk #Survival #Treatment Outcome #Tretinoin
Tipo

article
Acesso ao item digital